Rare Disease Trial, Not Yet Recruiting (NCT07666269)

Rare Disease Trial, Not Yet Recruiting NCT07666269 Sponsor: University Hospital, Bordeaux Condition: Rare Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07666269 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Rare Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For patients: You have been diagnosed with a rare bone or cartilage condition, confirmed (either through genetic testing and/or clinical assessment) by a specialist rare disease centre focused on bone disorders or calcium and phosphate metabolism issues.
You are able to have a 3D digital scan taken of the inside of your mouth.
You are able to understand the information provided about how your medical data and 3D mouth scans will be used for research, and can confirm you are happy for them to be used.
For healthy volunteers: You are a healthy adult being seen in a dental medicine department.

Who may not be able to join:

You have previously had significant orthodontic treatment (such as braces) or jaw surgery.
You have a facial or skull condition that is not related to the diseases being studied in this trial (for example, a cleft palate or another unrelated facial syndrome).
It is not possible to obtain a 3D digital scan of your mouth for any reason.
You are unwilling or unable to understand the research information provided, or you do not wish to give your agreement for your data to be used in this study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 05 47 30 43 01

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07666269

Sponsor: University Hospital, Bordeaux

Phase: Not Applicable

Status: Not Yet Recruiting

Condition: Rare Disease

Trial contact: 05 47 30 43 01

More information: https://clinicaltrials.gov/study/NCT07666269

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

For patients: You have been diagnosed with a rare bone or cartilage condition, confirmed (either through genetic testing and/or clinical assessment) by a specialist rare disease centre focused on bone disorders or calcium and phosphate metabolism issues.
You are able to have a 3D digital scan taken of the inside of your mouth.
You are able to understand the information provided about how your medical data and 3D mouth scans will be used for research, and can confirm you are happy for them to be used.
For healthy volunteers: You are a healthy adult being seen in a dental medicine department.

Who may not be able to join:

You have previously had significant orthodontic treatment (such as braces) or jaw surgery.
You have a facial or skull condition that is not related to the diseases being studied in this trial (for example, a cleft palate or another unrelated facial syndrome).
It is not possible to obtain a 3D digital scan of your mouth for any reason.
You are unwilling or unable to understand the research information provided, or you do not wish to give your agreement for your data to be used in this study.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Not Yet Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Bordeaux

Registry

ClinicalTrials.gov

Start date

1 September 2026

Est. completion

1 March 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Discriminative ability of geometric morphometric analysis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov